List of Tables
Table 1. Viral Gene Therapy Market Trends
Table 2. Viral Gene Therapy Market Drivers & Opportunity
Table 3. Viral Gene Therapy Market Challenges
Table 4. Viral Gene Therapy Market Restraints
Table 5. Global Viral Gene Therapy Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Viral Gene Therapy Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Viral Gene Therapy Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Viral Gene Therapy Product Type
Table 9. Key Companies Time to Begin Mass Production of Viral Gene Therapy
Table 10. Global Viral Gene Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Viral Gene Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Viral Gene Therapy Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Viral Gene Therapy Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Viral Gene Therapy Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Viral Gene Therapy Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Viral Gene Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Viral Gene Therapy Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Viral Gene Therapy Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Viral Gene Therapy Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Viral Gene Therapy Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Viral Gene Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Viral Gene Therapy Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Viral Gene Therapy Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Viral Gene Therapy Sales Value by Region (2019-2024) & (%)
Table 27. Global Viral Gene Therapy Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Viral Gene Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Viral Gene Therapy Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Viral Gene Therapy Sales Value, (2025-2030) & (US$ Million)
Table 31. Lonza Basic Information List
Table 32. Lonza Description and Business Overview
Table 33. Lonza Viral Gene Therapy Products, Services and Solutions
Table 34. Revenue (US$ Million) in Viral Gene Therapy Business of Lonza (2019-2024)
Table 35. Lonza Recent Developments
Table 36. Biogen Basic Information List
Table 37. Biogen Description and Business Overview
Table 38. Biogen Viral Gene Therapy Products, Services and Solutions
Table 39. Revenue (US$ Million) in Viral Gene Therapy Business of Biogen (2019-2024)
Table 40. Biogen Recent Developments
Table 41. Catalent Basic Information List
Table 42. Catalent Description and Business Overview
Table 43. Catalent Viral Gene Therapy Products, Services and Solutions
Table 44. Revenue (US$ Million) in Viral Gene Therapy Business of Catalent (2019-2024)
Table 45. Catalent Recent Developments
Table 46. Gilead Sciences Basic Information List
Table 47. Gilead Sciences Description and Business Overview
Table 48. Gilead Sciences Viral Gene Therapy Products, Services and Solutions
Table 49. Revenue (US$ Million) in Viral Gene Therapy Business of Gilead Sciences (2019-2024)
Table 50. Gilead Sciences Recent Developments
Table 51. Sarepta Therapeutics Basic Information List
Table 52. Sarepta Therapeutics Description and Business Overview
Table 53. Sarepta Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 54. Revenue (US$ Million) in Viral Gene Therapy Business of Sarepta Therapeutics (2019-2024)
Table 55. Sarepta Therapeutics Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Viral Gene Therapy Products, Services and Solutions
Table 59. Revenue (US$ Million) in Viral Gene Therapy Business of Novartis (2019-2024)
Table 60. Novartis Recent Developments
Table 61. Amgen Basic Information List
Table 62. Amgen Description and Business Overview
Table 63. Amgen Viral Gene Therapy Products, Services and Solutions
Table 64. Revenue (US$ Million) in Viral Gene Therapy Business of Amgen (2019-2024)
Table 65. Amgen Recent Developments
Table 66. Ionis Pharmaceuticals Basic Information List
Table 67. Ionis Pharmaceuticals Description and Business Overview
Table 68. Ionis Pharmaceuticals Viral Gene Therapy Products, Services and Solutions
Table 69. Revenue (US$ Million) in Viral Gene Therapy Business of Ionis Pharmaceuticals (2019-2024)
Table 70. Ionis Pharmaceuticals Recent Developments
Table 71. Spark Therapeutics Basic Information List
Table 72. Spark Therapeutics Description and Business Overview
Table 73. Spark Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 74. Revenue (US$ Million) in Viral Gene Therapy Business of Spark Therapeutics (2019-2024)
Table 75. Spark Therapeutics Recent Developments
Table 76. Shanghai Sunway Biotech Basic Information List
Table 77. Shanghai Sunway Biotech Description and Business Overview
Table 78. Shanghai Sunway Biotech Viral Gene Therapy Products, Services and Solutions
Table 79. Revenue (US$ Million) in Viral Gene Therapy Business of Shanghai Sunway Biotech (2019-2024)
Table 80. Shanghai Sunway Biotech Recent Developments
Table 81. SIBIONO Basic Information List
Table 82. SIBIONO Description and Business Overview
Table 83. SIBIONO Viral Gene Therapy Products, Services and Solutions
Table 84. Revenue (US$ Million) in Viral Gene Therapy Business of SIBIONO (2019-2024)
Table 85. SIBIONO Recent Developments
Table 86. AnGes Basic Information List
Table 87. AnGes Description and Business Overview
Table 88. AnGes Viral Gene Therapy Products, Services and Solutions
Table 89. Revenue (US$ Million) in Viral Gene Therapy Business of AnGes (2019-2024)
Table 90. AnGes Recent Developments
Table 91. Orchard Therapeutics Basic Information List
Table 92. Orchard Therapeutics Description and Business Overview
Table 93. Orchard Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 94. Revenue (US$ Million) in Viral Gene Therapy Business of Orchard Therapeutics (2019-2024)
Table 95. Orchard Therapeutics Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Viral Gene Therapy Downstream Customers
Table 99. Viral Gene Therapy Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Viral Gene Therapy Product Picture
Figure 2. Global Viral Gene Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 4. Viral Gene Therapy Report Years Considered
Figure 5. Global Viral Gene Therapy Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Viral Gene Therapy Revenue in 2023
Figure 7. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Integrating Viral Vectors Picture
Figure 9. Non-Integrating Viral Vectors Picture
Figure 10. Global Viral Gene Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Viral Gene Therapy Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Metabolic Diseases
Figure 13. Product Picture of Cardiovascular Diseases
Figure 14. Product Picture of Muscular Diseases
Figure 15. Product Picture of Hematologic Diseases
Figure 16. Product Picture of Ophthalmologic Diseases
Figure 17. Product Picture of Infectious Diseases
Figure 18. Product Picture of Others
Figure 19. Global Viral Gene Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Viral Gene Therapy Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Viral Gene Therapy Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Viral Gene Therapy Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Viral Gene Therapy Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Viral Gene Therapy Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Viral Gene Therapy Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Viral Gene Therapy Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Viral Gene Therapy Sales Value (%), (2019-2030)
Figure 32. United States Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 38. China Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 40. China Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 50. India Viral Gene Therapy Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Viral Gene Therapy Sales Value by Type (%), 2023 VS 2030
Figure 52. India Viral Gene Therapy Sales Value by Application (%), 2023 VS 2030
Figure 53. Viral Gene Therapy Industrial Chain
Figure 54. Viral Gene Therapy Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
